This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
COPD is a progressive inflammatory process affecting both the airways and alveolar structures of the lungs. Exacerbations of COPD are episodes of acute worsening of this inflammatory process, often triggered by infections. The most severe exacerbations are characterized by substantial air trapping and inspiratory muscle overload, which leads to hypercapnic respiratory failure. Pharmacologic therapies focus on intense bronchodilator administration (usually by aerosol), corticosteroids, and antibiotics. Respiratory life support technologies are often needed for severe exacerbations and range from carefully titrated supplemental O2 administration to positive-pressure ventilation (both invasive and noninvasive). Future life support strategies will likely involve extracorporeal life support technologies.
- COPD
- COPD exacerbations
- inspiratory muscle overload
- air trapping (intrinsic PEEP)
- hypercapnic respiratory failure
- positive-pressure ventilation (invasive and noninvasive)
Footnotes
- Correspondence: Neil R MacIntyre MD FAARC, Duke University Medical Center, Durham, NC. E-mail: neil.macintyre{at}duke.edu
Dr MacIntyre discloses relationships with Baxter and Inogen.
Dr MacIntyre presented a version of this paper at the 59th Respiratory Care Journal Conference, “COPD: Current Evidence and Implications for Practice,” held June 21–22, 2022, in St. Petersburg, Florida.
- Copyright © 2023 by Daedalus Enterprises
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.